These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16855006)

  • 1. Activation of corticotropin-releasing factor receptor-2 causes bronchorelaxation and inhibits pulmonary inflammation in mice.
    Moffatt JD; Lever R; Page CP
    FASEB J; 2006 Sep; 20(11):1877-9. PubMed ID: 16855006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
    Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
    J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
    Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
    J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery.
    Schilling L; Kanzler C; Schmiedek P; Ehrenreich H
    Br J Pharmacol; 1998 Nov; 125(6):1164-71. PubMed ID: 9863643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats.
    Kamdi SP; Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
    Appetite; 2009 Dec; 53(3):354-62. PubMed ID: 19635511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
    de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
    J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortin 1 inhibits guinea pig gallbladder contractility in vitro via corticotropin-releasing factor receptor 2.
    Abd El-Aziz SM; Abdel-Wahab BA
    Can J Physiol Pharmacol; 2011 Nov; 89(11):783-91. PubMed ID: 22007876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2.
    Martínez V; Wang L; Rivier JE; Vale W; Taché Y
    J Pharmacol Exp Ther; 2002 May; 301(2):611-7. PubMed ID: 11961064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of CRH receptors in urocortin-induced hyperthermia.
    Telegdy G; Adamik A
    Peptides; 2008 Nov; 29(11):1937-42. PubMed ID: 18775757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
    Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety.
    Todorovic C; Radulovic J; Jahn O; Radulovic M; Sherrin T; Hippel C; Spiess J
    Eur J Neurosci; 2007 Jun; 25(11):3385-97. PubMed ID: 17553007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear.
    Stiedl O; Meyer M; Jahn O; Ogren SO; Spiess J
    J Pharmacol Exp Ther; 2005 Mar; 312(3):905-16. PubMed ID: 15537825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of urocortin, corticotropin-releasing factor (CRF) receptor agonist, and astressin, CRF receptor antagonist, on the sleep-wake pattern: analysis by radiotelemetry in conscious rats.
    Uchida M; Suzuki M; Shimizu K
    Biol Pharm Bull; 2007 Oct; 30(10):1895-7. PubMed ID: 17917258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urocortin-induced relaxation in the human internal mammary artery.
    Chen ZW; Huang Y; Yang Q; Li X; Wei W; He GW
    Cardiovasc Res; 2005 Mar; 65(4):913-20. PubMed ID: 15721872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia.
    Larson AA; Nunez MG; Kissel CL; Kovács KJ
    Eur J Neurosci; 2015 Nov; 42(10):2772-82. PubMed ID: 26332847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral and central administration of exogenous urocortin 1 disrupts the fasted motility pattern of the small intestine in rats via the corticotrophin releasing factor receptor 2 and a cholinergic mechanism.
    Yin Y; Dong L; Yin D
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e79-87. PubMed ID: 17944898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
    Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
    Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.
    Perrin MH; Sutton S; Bain DL; Berggren WT; Vale WW
    Endocrinology; 1998 Feb; 139(2):566-70. PubMed ID: 9449626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2.
    Wang L; Martínez V; Rivier JE; Taché Y
    Am J Physiol Regul Integr Comp Physiol; 2001 Nov; 281(5):R1401-10. PubMed ID: 11641109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.